Andrews Nancy C 4
4 · Maze Therapeutics, Inc. · Filed Sep 24, 2025
Insider Transaction Report
Form 4
Andrews Nancy C
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-09-22+18,000→ 18,000 totalExercise: $23.67Exp: 2035-09-21→ Common Stock (18,000 underlying)
Footnotes (1)
- [F1]The option shall vest as to 1/9 of the total award monthly with the first tranche vesting on October 1, 2025, subject to the reporting person's continued service to the Issuer on the applicable vesting date.